Quantum-Si Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 145

Employees

  • Stock Symbol
  • QSI

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.91
  • (As of Friday Closing)

Quantum-Si General Information

Description

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Contact Information

Formerly Known As
HighCape Capital Acquisition
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 29 Business Park Drive
  • Unit Suite C
  • Branford, CT 06405
  • United States
+1 (203)
Primary Industry
Discovery Tools (Healthcare)
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 29 Business Park Drive
  • Unit Suite C
  • Branford, CT 06405
  • United States
+1 (203)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quantum-Si Stock Performance

As of 20-Nov-2026, Quantum-Si’s stock price is $0.91. Its current market cap is $200M with 220M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.91 $1.07 $0.69 - $1.81 $200M 220M 6.87M -$0.39

Quantum-Si Financials Summary

As of 30-Sep-2026, Quantum-Si has a trailing 12-month revenue of $1.26M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 125,718 15,805 202,806 25,699
Revenue 1,265 2,436 3,058 1,082
EBITDA (87,159) (105,791) (105,989) (92,263)
Net Income (85,132) (101,339) (101,007) (95,960)
Total Assets 172,887 245,607 247,871 298,250
Total Debt 2,777 4,166 12,948 15,303
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Quantum-Si Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Quantum-Si‘s full profile, request access.

Request a free trial

Quantum-Si Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Quantum-Si‘s full profile, request access.

Request a free trial

Quantum-Si Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single
Discovery Tools (Healthcare)
Branford, CT
145 As of 2025

Seattle, WA
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quantum-Si Competitors (5)

One of Quantum-Si’s 5 competitors is Nautilus Biotechnology, a Formerly VC-backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nautilus Biotechnology Formerly VC-backed Seattle, WA
Seer Formerly VC-backed Redwood City, CA
Olink Proteomics Formerly PE-Backed Uppsala, Sweden
SomaLogic Operating Company Formerly PE-Backed Boulder, CO
Illumina Formerly VC-backed San Diego, CA
You’re viewing 5 of 5 competitors. Get the full list »

Quantum-Si Patents

Quantum-Si Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260171192-A1 Techniques for detecting amino acid variants using next-generation protein sequencing Pending 17-Dec-2024
WO-2026136555-A1 Techniques for detecting amino acid variants using next-generation protein sequencing Pending 17-Dec-2024
WO-2026117728-A1 Improved library preparation for polypeptide sequencing Pending 27-Nov-2024
US-20260140120-A1 Spatially-multiplexed fluorescence imaging Pending 19-Nov-2024
WO-2026112053-A1 Spatially-multiplexed fluorescence imaging Pending 19-Nov-2024 G01N33/6818
To view Quantum-Si’s complete patent history, request access »

Quantum-Si Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quantum-Si Acquisitions (2)

Quantum-Si’s most recent deal was a Merger/Acquisition with Majelac Technolgies for . The deal was made on 05-Nov-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Majelac Technolgies 05-Nov-2021 Merger/Acquisition Other Containers and Packaging
HighCape Capital Acquisition 10-Jun-2021 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Quantum-Si’s complete acquisitions history, request access »

Quantum-Si ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

21.6 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 67

Rank

Percentile

To view Quantum-Si’s complete esg history, request access »

Quantum-Si FAQs

  • When was Quantum-Si founded?

    Quantum-Si was founded in 2013.

  • Where is Quantum-Si headquartered?

    Quantum-Si is headquartered in Branford, CT.

  • What is the size of Quantum-Si?

    Quantum-Si has 145 total employees.

  • What industry is Quantum-Si in?

    Quantum-Si’s primary industry is Discovery Tools (Healthcare).

  • Is Quantum-Si a private or public company?

    Quantum-Si is a Public company.

  • What is Quantum-Si’s stock symbol?

    The ticker symbol for Quantum-Si is QSI.

  • What is the current stock price of Quantum-Si?

    As of 20-Nov-2026 the stock price of Quantum-Si is $0.91.

  • What is the current market cap of Quantum-Si?

    The current market capitalization of Quantum-Si is $200M.

  • What is Quantum-Si’s current revenue?

    The trailing twelve month revenue for Quantum-Si is $1.26M.

  • Who are Quantum-Si’s competitors?

    Nautilus Biotechnology, Seer, Olink Proteomics, SomaLogic Operating Company, and Illumina are competitors of Quantum-Si.

  • What is Quantum-Si’s annual earnings per share (EPS)?

    Quantum-Si’s EPS for 12 months was -$0.39.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process